Related Experiment Videos
How I treat autoimmune hemolytic anemia
Ronald S Go1, Jeffrey L Winters2, Neil E Kay1
1Division of Hematology, Department of Medicine, and.
Blood
|April 1, 2017
Summary
Autoimmune hemolytic anemia (AIHA) presents complex diagnostic and treatment challenges. This review offers practical guidance and algorithms for personalized AIHA management, including difficult negative test cases.
Area of Science:
- Hematology
- Immunology
- Internal Medicine
Background:
- Autoimmune hemolytic anemia (AIHA) remains a diagnostic and therapeutic challenge despite being recognized for over 150 years.
- Significant heterogeneity in hemolysis rates, associated diseases, and clinical presentation complicates management.
- A lack of robust clinical trials hinders the development of standardized, evidence-based therapeutic guidelines.
Observation:
- This review presents four clinical vignettes illustrating distinct AIHA presentations and tailored diagnostic/therapeutic pathways.
- Key diagnostic parameters offering prognostic insight are reviewed.
- Algorithms for AIHA diagnosis and treatment in varied clinical scenarios are provided.
Findings:
- The study outlines practical approaches to AIHA diagnosis and management based on clinical experience.
- It emphasizes personalized therapy recommendations derived from diagnostic insights and clinical heterogeneity.
- Specific guidance is offered for diagnosing AIHA cases with negative test results.
Implications:
- This review aims to provide clinicians with practical guidance for managing AIHA, improving patient outcomes.
- It supports the development of personalized therapeutic strategies for autoimmune hemolytic anemia.
- The work addresses a critical need for updated, evidence-based approaches in AIHA patient care.